Abstract purpose: Our objectives were to assess whether plasma neuropeptide Y (NPY)
levels are elevated in patients with congestive heart failure (CHF) and whether or not NPY …

OBJECTIVE--To measure plasma concentrations of noradrenaline and neuropeptide Y-like
immunoreactivity in relation to cardiac function in patients with congestive heart failure …

Neuropeptide Y (NPY) is colocalised with noradrenaline in post‐ganglionic sympathetic
neurons. In order to examine the possibility that activation of the sympathetic nervous system …

Abstract Aims Neuropeptide Y (NPY) is the most abundant neuropeptide found in the heart
and is released alongside norepinephrine following prolonged sympathetic activation, a …

Neuropeptide Y (NPY) coexists with noradrenaline in postganglionic sympathetic neurons.
In order to test the hypothesis that NPY may be released along with catecholamines by …

Plasma neuropeptide Y-like immunoreactivity (NPY-LI) is elevated in patients with acute
myocardial ischaemia and congestive heart failure (CHF) owing to increased activity of the …

Neuropeptide Y coexists with norepinephrine in sympathetic nerves and is coreleased into
the circulation on sympathetic activation. Little is known about the regional release of …

Study objective–The aim of the study was to measure plasma neuropeptide Y, which is
related to sympathetic nerve stimulation, in patients admitted to a coronary care unit and to …

Neuropeptide Y (NPY) is contained in and coreleased with norepinephrine (NE) from
sympathetic nerves innervating vascular and cardiac tissues. The effects of NPY infusion on …

Congestive heart failure and other cardiac diseases are characterized by increased activity
of the sympathetic nervous system, whereas at the same time parasympathetic activity is …